XML 38 R27.htm IDEA: XBRL DOCUMENT v3.25.2
Stock-Based Compensation (Tables)
6 Months Ended
Jun. 30, 2025
Share-Based Payment Arrangement [Abstract]  
Schedule of stock option activity under all of the Company's equity incentive plans

    

    

    

    

Weighted

    

Weighted

Average

Shares

Number of

Average

Remaining

Aggregate

Available for

Shares

Exercise

Contractual

Intrinsic

Grant

Outstanding

Price

Life (Years)

Value (000’s)

Available and outstanding as of December 31, 2024

92,020

296,391

$

50.50

7.97

$

26

2022 Equity incentive plan increase

220,106

Granted

 

(33,876)

 

33,876

 

4.59

 

 

Forfeited

 

15,316

 

(15,316)

 

70.08

 

 

Available and outstanding as of June 30, 2025

293,566

314,951

$

44.56

7.75

$

Vested and exercisable as of June 30, 2025

 

169,957

$

61.66

 

6.60

$

 

Schedule of assumptions utilized for option grants

    

Three Months Ended

    

Six Months Ended

June 30, 

June 30, 

2025

    

2024

 

2025

    

2024

 

Risk-free interest rate

 

4.03

%  

4.20

%

 

4.11

%  

4.20

%

Expected dividend yield

 

%  

%

 

%  

%

Expected volatility

51.71

%  

54.30

%

 

52.37

%  

54.35

%

Expected term (in years)

 

6.1

 

5.8

 

6.1

 

5.7

 

Schedule of stock-based compensation expense recognized in the Company's consolidated statements of operations

    

Three Months Ended

    

Six Months Ended

June 30, 

June 30, 

2025

    

2024

2025

    

2024

Cost of revenue, net

$

40

$

8

$

86

$

65

Research and development

 

115

 

146

 

263

 

268

Sales and marketing

 

22

 

32

 

43

 

80

General and administrative

 

208

 

83

 

415

 

190

Total

$

385

$

269

$

807

$

603